BDBM50143852 CHEMBL65525::{2-[2-(4-Carbamimidoyl-phenyl)-1-oxo-2,8-diaza-spiro[4.5]dec-8-yl]-2-oxo-ethoxy}-acetic acid

SMILES NC(=N)c1ccc(cc1)N1CCC2(CCN(CC2)C(=O)COCC(O)=O)C1=O

InChI Key InChIKey=TWXBFWRQAKTFER-UHFFFAOYSA-N

Data  8 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 8 hits for monomerid = 50143852   

TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50143852(CHEMBL65525 | {2-[2-(4-Carbamimidoyl-phenyl)-1-oxo...)
Affinity DataIC50:  108nMAssay Description:Inhibition of platelet aggregation induced by 20 microM adenosine 5-diphosphate (ADP) in citrated human platelet rich plasma (h-PRP)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50143852(CHEMBL65525 | {2-[2-(4-Carbamimidoyl-phenyl)-1-oxo...)
Affinity DataIC50: >5.00E+4nMAssay Description:Inhibition of vitronectin binding to Vitronectin receptor (alpha V beta 3)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50143852(CHEMBL65525 | {2-[2-(4-Carbamimidoyl-phenyl)-1-oxo...)
Affinity DataIC50:  17nMAssay Description:Tested for inhibition of the binding of fibrinogen to purified human GPIIb-IIIa in a 96-well format (ELISA assay)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50143852(CHEMBL65525 | {2-[2-(4-Carbamimidoyl-phenyl)-1-oxo...)
Affinity DataIC50:  393nMAssay Description:Inhibition of citrated human platelet (h-PRP) aggregation induced by 4 ug/mL collagenMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50143852(CHEMBL65525 | {2-[2-(4-Carbamimidoyl-phenyl)-1-oxo...)
Affinity DataIC50:  108nMAssay Description:Inhibition of human platelet (h-PRP) aggregation induced by 20 microM ADP with PPACKMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50143852(CHEMBL65525 | {2-[2-(4-Carbamimidoyl-phenyl)-1-oxo...)
Affinity DataIC50:  691nMAssay Description:Inhibition of human platelet (h-PRP) aggregation induced by 5 microM TRAP6 with PPACKMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50143852(CHEMBL65525 | {2-[2-(4-Carbamimidoyl-phenyl)-1-oxo...)
Affinity DataIC50:  273nMAssay Description:Inhibition of citrated human (h-PRP) platelet aggregation induced by 5 uM TRAP6More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Millennium Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50143852(CHEMBL65525 | {2-[2-(4-Carbamimidoyl-phenyl)-1-oxo...)
Affinity DataIC50:  812nMAssay Description:Inhibition of human platelet (h-PRP) aggregation induced by 4 ug/mL collagen with PPACKMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed